Oligonucleotide N3′→P5′ phosphoramidates as efficient telomerase inhibitors

[1]  T. Nyholm,et al.  Nucleosides Nucleotides Nucleic Acids , 2003 .

[2]  D. Corey,et al.  Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells. , 2001, Nucleic acids research.

[3]  C. Harley,et al.  Telomerase inhibitors--oligonucleotide phosphoramidates as potential therapeutic agents. , 2001, Nucleosides, nucleotides & nucleic acids.

[4]  Jiunn-Liang Chen,et al.  Secondary Structure of Vertebrate Telomerase RNA , 2000, Cell.

[5]  D. V. Von Hoff,et al.  G-quadruplexes as targets for drug design. , 2000, Pharmacology & therapeutics.

[6]  S. Neidle,et al.  Structure-activity relationships among guanine-quadruplex telomerase inhibitors. , 2000, Pharmacology & therapeutics.

[7]  S. Gryaznov.  Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents. , 1999, Biochimica et biophysica acta.

[8]  D. Corey,et al.  Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  K. Pongracz,et al.  Oligonucleotide N3′→P5′ thiophosphoramidates: synthesis and properties , 1999 .

[10]  W. Hahn,et al.  Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.

[11]  H. Koeffler,et al.  5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. , 1999, Cancer research.

[12]  T. Tsuruo,et al.  FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. , 1999, Cancer research.

[13]  E. Matthes,et al.  Telomerase protein rather than its RNA is the target of phosphorothioate-modified oligonucleotides. , 1999, Nucleic acids research.

[14]  D. Corey,et al.  Inhibition of human telomerase by 2'-O-methyl-RNA. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Tsuruo,et al.  Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. , 1998, Biochemical and biophysical research communications.

[16]  S. Akhtar,et al.  Synthetic 2'-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity. , 1998, Antisense & nucleic acid drug development.

[17]  A. Glukhov,et al.  Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides. , 1998, Biochemical and biophysical research communications.

[18]  R. Silverman,et al.  Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA , 1998, Oncogene.

[19]  J. Devlin,et al.  Identification of a series of potent telomerase inhibitors using a time‐resolved fluorescence‐based assay , 1998 .

[20]  D. Corey,et al.  Inhibition of human telomerase activity by peptide nucleic acids , 1996, Nature Biotechnology.

[21]  H. W. Sharma,et al.  Telomerase as a potential molecular target to study G-quartet phosphorothioates. , 1996, Antisense & nucleic acid drug development.

[22]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[23]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[24]  H Shindo,et al.  Nucleic Acids , 1932, Nature.